These three treatments also resulted in a significantly higher expression of cleaved caspase-9 in tumours with an increase of 85.2% (P < 0.001), 68.4% (P < 0.001), and 21.3% (P < 0.05), respectively (Fig. 3B, D). This evidence concerns the gene CASP9 and neoplasm.